Health
Metformin drug decreases mortality rate in COVID-19 patients with type 2 diabetes – News-Medical.Net
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure.”
Anath Shalev, M.D, Study Lead Author and Director of…
-
Noosa News22 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
General18 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoWest End icon closes doors
-
General18 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire